Rob PeetsAdherex TechnologiesIncFENCFWAITJan 28, 2003

Interesting technology. Treatment is in early clinical trials.

Rob Peets

Unknown

Unlock Rating

$0.36

Stock price when the opinion was issued

biotechnologypharmaceutical

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

DON'T BUY

Products are a little bit away from commercialization.

Most Recent Experts

Jim Cramer - Mad Money

CNBC

John Zechner

J. Zechner & Assoc

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Keith Richards

ValueTrend Wealth Management

Joe Terranova

Virtus Investment Partners

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Rob PeetsAdherex TechnologiesIncFENCFWAITJan 28, 2003

You might be interested:

Adherex TechnologiesInc(FENCF)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals